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ABSTRACT 
 
Lawrence Bacudio: 
Muscle fiber-type switch in acyl-CoA synthetase-1 knockout mice 
(under direction of Rosalind A. Coleman) 
 
The product of the Acsl1 gene activates fatty acids for β-oxidation in aerobic respiration. 
Without ACSL1, type I fibers, which primarily depend on fatty acids, may not be able to produce 
energy. In this study, we have shown that muscle-specific ACSL1 is important in skeletal muscle 
fiber type and structure. Mice with muscle-specific Acsl1 deletions developed centronuclear 
myopathies, accompanied by an increase in creatine kinase activity and myofiber conversion 
from glycolytic to oxidative. To investigate this myofiber conversion, molecular activators of 
PGC1α, such as SIRT1 and AMPK, were measured but we found that their role is not 
significant. Our findings reveal an essential role of ACSL1 in myofiber identity, skeletal muscle 
structure, and development of centronuclear myopathies. 
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CHAPTER 1: INTRODUCTION 
 
1.1 ACSL1 
Biological enzymes govern which specific fuel substrates would be used by skeletal 
muscles. Long-chain acyl-CoA synthetases (ACSLs) activate long-chain fatty acids (LCFAs) 
either for β-oxidation or for biosynthesis of cholesterols, triacylglycerols (TAGs), or 
phospholipids1. Once activated, LCFAs are converted to acyl-CoAs, molecules known to 
participate in a wide-range of anabolic and catabolic reactions. A separate gene encodes each 
of the five isoforms (ACSLs 1, 3-6) of the ACSL family of enzymes, whereby each isoform 
affects how fatty acids (FAs) are to be metabolically used2. In particular, the ACSL1 isoform 
specifically targets LCFAs for β-oxidation especially in highly oxidative tissues, but it may also 
target them for lipid biosynthesis in other tissues3. Although the ACSL isoforms have been 
shown to participate in FA metabolism, their role in skeletal muscle remains largely unknown. 
Recent reports indicate, however, that skeletal muscle-specific Acsl1 knockout (Acsl1M-/-) have 
significantly decreased FA oxidation, greater insulin sensitivity, and greater glucose use 
compared to control mice4. Similarly, hearts with temporarily induced Acsl1 knockout had 
greater glucose use, more mitochondria, and reduced activated AMP-activated protein kinase 
(AMPK) compared to control mice9. 
 
1.2 Muscle fiber types 
Skeletal muscle type I and type II are the main types of skeletal muscle fibers that are 
vital for support and locomotion. Type I fibers maintain posture and support; thus they are 
predominant in posterior muscles such as the soleus, erector spinae, and quadratus 
lumborum19. Type I fibers contain high concentrations of myoglobin, and they are densely 
surrounded by capillaries20. These high concentrations of myoglobin give type I fibers their  
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bright red color16. The slow contraction of these fibers is due to the slow calcium release and 
reabsorption of the sarcoplasmic reticuli and slow adenosine triphosphate (ATP) hydrolysis17. 
Type I fibers primarily depend on aerobic respiration to produce energy; thus limiting lactic acid 
production22. Saladin reports that type I fibers are thinner, more oxidative, and more 
mitochondria-rich than type II fibers. A greater number of type I fibers is linked to higher 
ATPmax and VO2max, which means a greater metabolic capacity compared to a greater type II 
fiber content, but the reason for this correlation is still unknown15. 
 Type II fast twitch muscle fibers contract forcefully and quickly; accordingly, they are 
predominant in forelimb muscles such as the gastrocnemius and biceps brachii14. Calcium 
release and reabsorption by the sarcoplasmic reticulum and ATP hydrolysis are relatively fast in 
these fibers17. In human skeletal muscle, scientists have subdivided type II fibers into 7 muscle 
fiber types20. However, in rat skeletal muscle, histochemical staining only recognizes three 
subdivisions: type IIa, type IIb, and type IIx. Type IIb fibers are fast glycolytic, quickly producing 
ATP22 but oxidative fibers produce more ATP. Type IIb fibers heavily rely on anaerobic 
respiration and fermentation, thus maximizing lactic acid production and minimizing fatigue 
resistance. Saladin reports that type IIb fibers have lower myoglobin content, fewer 
mitochondria, and fewer capillaries than type I fibers. This low myoglobin content gives type IIb 
fibers their pale color. On the other hand, type IIa fibers are oxidative glycolytic, heavily relying 
on glycolysis and aerobic respiration to produce ATP19. Similar to type I, type IIa fibers have 
abundant mitochondria and great fatigue resistance15. Scientists have found that in cat 
gastrocnemius, succinate dehydrogenase (SDH) staining is stronger in type IIa but weaker in 
type IIb fibers11. Type IIx fiber, an intermediate between type IIa and IIb fiber, was identified in 
rodent skeletal muscle18.  
 Since myosin is a motor protein involved in muscle contraction, muscle fiber types are 
identified by quantifying the expression of myosin heavy chain (MHC) isoforms19. Importantly,  
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each muscle fiber type expresses only a single MHC isoform12. Accordingly, Smerdu et al. found 
that genes encoding rodent MHC IIa, IIb, and IIx differ from one another. Humans have similar 
MHC composition but histochemical analysis do not detect the expression of MHC IIx. 
Therefore, type IIx fibers do not exist in human skeletal muscles21 and mice models of skeletal 
muscle fiber type composition may not be as representative to humans.  
Because FA use as fuel becomes limited without ACSL1, which activates FAs for β-
oxidation for aerobic respiration, we hypothesized that muscle fibers would switch from type I to 
type II in Acsl1M-/-. To examine fiber type switching, the mRNA expression of different MHC 
isoforms in mouse gastrocnemius was quantified using real-time polymerase chain reaction 
(qPCR). If type I fibers do indeed switch to type II fibers in Acsl1M-/- gastrocnemius, MHC I 
expression should be lower than in wildtype gastrocnemius. Consequently, type II fibers should 
increase in both type II-predominant and type I-predominant muscles. To investigate the 
presence of myofiber conversion in Acsl1M-/-, we used immunohistochemical analysis using a 
stain for SDH since type I fibers stain more intensely than type II fibers. Another distinction is 
relative diameter of the fiber, since the circumference of type I fibers is smaller than type II 
fibers17. Although fiber type switching may occur, the signaling pathway for the switch is 
unknown. For example, oxidative fibers type I and type IIa switch to glycolytic fibers type IIb and 
type IIx in skeletal muscle-specific peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (PGC1α) knockout mice13. Handschin et al. found that compared to control 
mice, these knockout mice had lower fatigue resistance and greater fiber damage after 
exercising on a treadmill for 3 days. Frequency of performing endurance exercises and the 
number of type I /IIa fibers were positively correlated, and this fiber-type switch increased insulin 
sensitivity15. Conversely, lack of physical activity correlated with fewer type I and type IIa fibers 
than control mice15. Compared to control mice, peroxisome proliferator-activated receptor alpha 
(PPARα)-deficient mice had a greater proportion of type I fibers, but mice with PPARα- 
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overexpression had a lower proportion of type I fibers; thus, abnormal PPARα expression 
induces fiber type switching.  
 
1.3 The PGC1α pathway 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 1. Transcriptional effects of PGC1α.  Activated AMPK phosphorylates PGC1α and then SIRT1 deacetylates 
PGC1α. PGC1α then binds to the promoter region of PGC1α to increase the mRNA synthesis related to 
mitochondrial biogenesis. With increased mitochondria, the capacity for aerobic respiration, and thus ATP production, 
is increased. Since a greater number of mitochondria is attributed to MHC I, PGC1α is thought to also increase MHC I 
and therefore increase type I muscle fibers. 
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 PGC1α is a transcriptional coactivator that has a key role in mitochondrial biogenesis 
and muscle energy metabolism28. With increased mitochondrial biogenesis, increase in type 1 
fibers is a strong possibility when PGC1α is hyperactivated. Like other transcriptional 
coactivators, many proteins are involved in activating PGC1α. For example, AMPK must first 
phosphorylate PGC1α before it gets deacetylated by SIRT1. Increased AMPK activation is 
moderated by its dephosphorylation, typically regulated by high AMP/ATP ratio, which results 
from exercise, starvation, or resveratrol29. SIRT1 functions as a deacetylase for both proteins 
and histones, which increases gene transcription usually as a result of calorie restriction29. The 
interactions between AMPK and SIRT1 also regulate other target molecules besides PGC1α. 
 
1.4 Obesity and Diabetes 
During normal insulin signaling, insulin binding to its receptor in the extracellular matrix 
activates the receptor’s tyrosine kinases, which autophosphorylate their own specific tyrosine 
residues. Intracellularly, insulin receptor substrate 1 (IRS1) binds to the receptor, which then 
activates it by phosphorylating tyrosine residues. Activated IRS1 then binds to and activates 
phosphatidylinositol 3-kinase (PI3K). When activated, PI3K phosphorylates phosphatidylinositol 
4,5-bisphosphate (PIP2) to form phosphatidylinositol-3,4,5-triphosphate (PIP3). PIP3 
phosphorylates and activates AKT, a kinase known to activate transcription factors, glycogen 
synthesis, protein synthesis, and glucose transporter type 4 (GLUT4) mobilization. Furthermore, 
AKT inhibits tuberous sclerosis complex 2 (TSC2), a protein that blocks the mammalian target 
of rapamycin (mTOR). mTOR is a pro-growth kinase that inhibits autophagy. 
Obese individuals typically have high serum lipids that contribute to TAG increase in 
non-adipocytes. As second messengers, excess intracellular lipid metabolites may increase 
serine phosphorylation of IRS-1, thereby preventing activation through tyrosine 
phosphorylation5. For example, diacylglycerol (DAG) activates protein kinase C (PKC) isoforms  
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that phosphorylate IRS-1 at serine and threonine residues6, prohibiting the signaling cascade 
that would otherwise occur with insulin signaling. Since AKT could not produce a downstream 
signal to mobilize GLUT4, glucose uptake by muscles and adipocytes in limited, resulting in high 
serum glucose, which is a diagnostic marker for diabetes and insulin resistance. In addition, due 
to hepatic insulin resistance, gluconeogenesis is continuously activated since there is limited 
cleavage of cyclic AMP (cAMP) to AMP by phosphodiesterase, an enzyme activated by insulin 
signaling. When subjects with Type II diabetes were treated with acipimox, a lipolytic inhibitor 
which should reduce lipid metabolites such as intramyocellular long-chain acyl-CoAs, their 
insulin sensitivity increased8. As such, high serum lipids, as seen in obesity, are associated with 
insulin resistance10. 
The study of muscle fiber type switching is important because muscle fiber types 
determine which substrate will be used for fuel. The manipulation of fiber type switching to 
increase FA use may allow patients to increase insulin sensitivity and thus decrease the effects 
of type 2 diabetes mellitus (T2DM) but more research need to be performed in order to explore 
this idea. For example, increasing the frequency of performing endurance exercises increases 
the number of slow oxidative fibers15 which may therefore be beneficial in preventing T2DM. 
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CHAPTER 2: STUDY AIMS AND HYPOTHESIS 
 
Our body is largely composed of skeletal muscles, which are important for structure, 
movement, and temperature homeostasis. In our study, we looked at whether muscle-specific 
Acsl1 knockout could induce myofiber conversion. ACSL1 activates LCFAs for β-oxidation in 
aerobic respiration. We previously found that Acsl1M-/- have significantly greater mitochondrial 
biogenesis than control mice in gastrocnemius. Since abundance of mitochondria distinguishes 
a fiber type, it may be possible that ACSL1 has a role in myofiber conversion. We hypothesize 
that Acsl1 deletion modulates an oxidative-to-glycolytic fiber type switch since activation of 
LCFAs for β-oxidation would be limited. To test our hypothesis, we have the following aims: 
 
AIM1. Determine what MHC isoform predominates in Acsl1M-/- 
Since lack of ACSL1 limits β-oxidation, the use of fatty acids for fuel would decrease. As such, 
we hypothesize that there would a switch towards the glycolytic fiber type. Thus, we would 
expect an increase in MHC IIb in Acsl1M-/-. 
AIM2. Determine what molecular mechanisms generated increased mitochondrial 
biogenesis in Acsl1M-/- 
PGC1α is a transcription factor involved in mitochondrial biogenesis and it is activated by SIRT1 
and AMPK. Thus, we hypothesized that there is increased expression of SIRT1 and AMPK in 
Acsl1M-/-. 
AIM3. Determine if Acsl1M-/- has myopathies 
It has been shown that myofiber conversion results in muscle fiber damage. Thus, we 
hypothesize that Acsl1M-/- have a centronuclear myopathy phenotype and increased kinase 
activity, both of which are markers for myofiber damage. 
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Materials 
15-week-old female mice (Acsl1M-/- and Acsl1loxp/loxp) were obtained from Liyang Zhao at 
Coleman Lab (NC). RNeasy Plus Mini Kit was obtained from Qiagen (MD). Universal SYBR 
Green Supermix and iScript cDNA Synthesis Kit were obtained from Bio-Rad (CA). Creatine 
kinase kit was obtained from Stanbio (TX). Colorimetric glucose kit was obtained from Sigma-
Aldrich (MO). Anti-Sirt1, anti-pAMPK, and anti-AMPK antibodies were obtained from Cell 
Signaling Technology (MA). Anti-GAPDH was obtained from Abcam (MA). Anti-MHC IIb, anti-
MHC I, and anti-MHC IIa antibodies were obtained from Developmental Studies Hybridoma 
Bank (IA). Secondary antibodies were obtained from Invitrogen (CA). Wheat germ agglutinin 
(WGA) was obtained from Fisher Scientific (NH). 
 
3.2 Methods 
3.2.1  Generation of Acsl1M-/- and collection of gastrocnemius samples 
 Controlled by the human skeletal actin (HSA) promoter, Cre recombinase-expressing 
mice were mated with floxed mice (Acsl1loxp/loxp). The resulting littermates (Acsl1loxp/loxp-HSACre) 
were mated with Acsl1loxp/loxp to generate Acsl1M-/- and the control Acsl1loxp/loxp. Protocols were 
approved by the University of North Carolina Institutional Animal Care and Use Committee 
(IACUC). Mice were anesthetized using tribromoethanol and white gastrocnemius was 
surgically separated from red gastrocnemius. Tissues were flash frozen in liquid nitrogen and 
manually pulverized using a mortar and pestle. 
3.2.2 mRNA expression of MHC isoforms 
Between 25-30 mg of the pulverized red and white gastrocnemius were homogenized. 
RNA was extracted using QIAGEN RNeasy Plus Mini Kit. After RNA extraction, 1 µg cDNA per  
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20 µL RNAse-free water was synthesized via reverse transcription by iScript cDNA Synthesis 
Kit. Using Bio-Rad CFX Connect Real-time, qPCR was performed to determine the gene 
expression of MHC I, MHC IIa, MHC IIb, MHC IIx, and a housekeeping gene (18S) in each of 
the cDNA samples. For the RT-PCR, CFX_3StepAmp+Melt protocol was used and Universal 
SYBR Green Supermix was used as a marker. The result was quantified by relative 
quantification method. Briefly, the Cq values of the myosin heavy chains were normalized to the 
Cq values of the housekeeping gene, and the average gene fold change in Acsl1M-/- mice was 
normalized by the gene fold change in Acsl1loxp/loxp.  
3.2.3 Quantification of type I muscle fibers 
Microscopy was performed on muscle tissue from Acsl1M-/- and Acsl1loxp/loxp mice. the 
gastrocnemius was cut transversely and collected. SDH staining was performed to detect 
mitochondria. The slides were digitally scanned by the UNC Translational Pathology Lab and 
images were analyzed using ImageJ.  the scanned images were converted to grayscale and the 
color threshold was manually adjusted to select for the cells that stained most intensely. A 
threshold was adjusted such that all the cells were selected in order to quantify the total area of 
the specimen. Type I fibers stain more intensely than type II fibers. For each genotype, the 
percentage of area covered by each fiber type was analyzed through a double-blinded study.  
3.2.4 Measuring glycogen content 
  Acsl1M-/- and Acsl1loxp/loxp mice were either fed or fasted for 17 h overnight. Tissue 
collection is outlined under 3.2.1 under Methods section. From each tissue, 20 mg of sample 
was used. Samples were then homogenized in 1M HCl using a blade-type homogenizer. To 
determine background glucose, 100 µL of homogenate was transferred on 1M NaOH. 
Remaining homogenates were heated at 95°C for 90 min. After cooling to room temperature 
(RT), samples were neutralized by adding 1M NaOH and spun at 14,000 g for 10 min. The 
supernatant was pipetted into wells with differing volumes: 10 µL from fed mice and 20 µL from  
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fasted mice. Total volume for each well was kept at 20 µL using 1:1 NaOH:HCl. Using a glucose 
kit, 300 µL of working reagent was added in each well. Samples were incubated at 37°C for 5 
min. Color intensity, which is proportional to the glycogen concentration, was measured at 490 
nm. 
3.2.5 Measuring creatine kinase activity 
  Blood was collected from mice, added to 0.5M ethylenediaminetetraacetic acid (EDTA), 
and spun at 10,000 rpm for 2 min at 4°C. Supernatants were collected and frozen in liquid 
nitrogen until used. Plasma samples were thawed and diluted 1:4 in phosphate-buffered saline 
(PBS) then 10 µL of samples were pipetted onto wells. From a creatine kinase kit, a working 
reagent was set at 37°C for 4 min and 200 µL were added to each well. Using the Cytation 3 
machine in the Hursting Lab (NC), measurements were collected after 2, 3 and 4 min at 37°C. 
3.2.6 Western blot analysis 
  White fiber gastrocnemius were homogenized and protein concentration in each sample 
was determined using the protein assay. 50 µg of protein was loaded onto 12% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and was separated at 120V for 90 
min. Separated proteins were transferred to nitrocellulose at 100V for 1 h and subjected to 
western blot analysis as follows: first, 5% non-fat dry milk was used to block non-specific 
binding to the membrane at 23°C for 30 min. The membranes were then incubated overnight at 
4°C with primary antibodies (Sirt1 1:1000, pAMPK 1:1000, AMPK 1:1000, GAPDH 1:30,000) 
diluted in 5% bovine serum albumin (BSA) in tris-buffered saline with Tween (TBS-T). The 
membranes were then incubated with secondary antibodies (1:5000) conjugated to horseradish 
peroxidase. Proteins were visualized using SuperSignal West Pico Chemiluminescent Substrate 
(Thermo Fisher Scientific, MA) and Molecular Imager VersaDoc (BioRad).  
3.2.7 Fluorescence microscopy 
  Cryosectioning of gastrocnemius samples was performed by the Histology Research  
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Core Facility (UNC). For fiber typing, tissues were fixed in 4% paraformaldehyde for 10 min on 
ice. Slides were washed in ice-cold PBS for 5 min, then cell membranes were permeabilized 
using 0.3% Triton for 15 min on ice. slides were washed in PBS twice for 5 min each. To block 
non-specific binding, 5% normal goat serum (NGS) was used. Slides were incubated with 5% 
NGS/PBS containing mouse anti-MHC IIb (1:25) for 2 h at RT and then they were incubated 
with goat anti-mouse-IgM-FITC (1:500) for 60 min at RT in the dark. Afterwards, slides were 
washed in PBS three times for 5 min each. Similarly, slides were fixed in 4% paraformaldehyde 
(PFA) and washed in PBS. Then, they were incubated with 5% NGS/PBS containing mouse 
anti-MHC I (1:25) for 2 h at RT. Afterwards, slides were incubated with goat anti-mouse IgG-
Rho (1:500) for 60 min at RT in the dark.  Slides were washed in PBS three times for 5 min 
each. Fluoroshield with DAPI histology mounting medium (Sigma-Aldrich, MO) was used to 
mount the coverslips onto the slides. To detect fluorescence, excitation wavelengths of 358 nm, 
488 nm, and 594 nm were used via EVOS FL Cell Imaging System at Hursting Lab (NC). 
3.2.8 Locating central nuclei 
  Tissues were fixed in 10% neutral buffered formalin for 10 min at RT and then were 
washed three times in PBS. WGA conjugate stock solution was diluted to 5 µg/mL in PBS. 
Tissues were incubated with labeling solution for 10 min at RT and then were washed twice in 
PBS. Fluoroshield with DAPI histology mounting medium was used to mount the coverslips onto 
the slides. To detect fluorescence, excitation wavelengths of 358 nm and 488 nm were used via 
EVOS FL Cell Imaging System at Hursting Lab (NC). 
3.2.9 Statistical analysis 
  Student’s t-test was used to compare the two genotypes. For the mRNA expression of 
MHC isoforms, Student’s t test was used to compare between the two genotypes for each MHC 
isoform. P < 0.05 was considered significant. 
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CHAPTER 4: RESULTS 
 
4.1 mRNA expression of MHC isoforms and fiber typing via SDH staining 
To investigate fiber type switching at the protein level, we measured mRNA expression 
of MHC isoforms via qPCR. In Acsl1M-/- gastrocnemius, mRNA expression of MHC I and MHC 
IIa differed from that of control mice (Fig. 2A and B). In white fiber gastrocnemius, Acsl1M-/- 
mRNA expression of MHC I was 563% higher compared to control mice (Fig. 2A). Compared 
with controls, Acsl1M-/- mRNA expression of MHC IIa was 58% lower in red fiber gastrocnemius 
(Fig. 2B). In white and red fiber gastrocnemius, Acsl1M-/- mRNA expression of MHC IIb and MHC 
IIx was not significantly different from that of controls (Fig. 2A and B). The percentage of 
oxidative fiber area in Acsl1M-/- gastrocnemius were significantly greater than that of control mice 
(Fig. 2C). 
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Figure 2. mRNA expression of MHC isoforms and fiber typing via SDH staining. Acsl1 deletion 
increased MHC I expression and type I fibers. A: mRNA expression of MHC isoforms in white fibers of gastrocnemius 
relative to 18S (females; nKO = 5, nWT = 3). B: mRNA expression of MHC isoforms in red fibers of gastrocnemius 
relative to 18S (females; nKO = 7, nWT = 3). C: Percentage of type I fiber area in total area of transversely sliced 
gastrocnemius stained with succinate dehydrogenase (females; n = 6). D: Histological sections of WT and Acsl1M-/- 
gastrocnemius with SDH staining.*P < 0.05 and **P<0.005, compared to control mice. 
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4.2 Glycogen content, creatine kinase activity, Sirt1 and AMPK protein expressions 
We investigated difference in glycogen content between control mice and Acsl1M-/- in fed 
and 17-h fasted states. No significant difference was observed between control mice and  
Acsl1M-/- in either the fed or fasted state (Fig. 3A). Oxidative fibers, such as type I and type IIa, 
contain more mitochondria than glycolytic fibers, such as type IIb. By knocking out Acsl1, 
mitochondrial content in white gastrocnemius was significantly greater than that of control mice 
(Fig. 3B). We also investigated muscle damage by measuring creatine kinase activity. Creatine 
kinase activity is a useful serum marker of muscle injury and oxidative stress23, resulting in 
increased cellular membrane permeability and therefore, increased movement of 
intramyocellular substrates, like creatine kinase, to the extracellular fluid. The creatine kinase 
activity was significantly greater in Acsl1M-/- compared to controls (Fig. 3C). Furthermore, we 
investigated the proteins involved in PGC1α activation, which is implicated in mitochondrial 
biogenesis28. We investigated AMPK and SIRT1, proteins involved in activating the 
transcriptional coactivator PGC1α. Via western immunoblotting, no significant differences were 
observed in SIRT1, AMPK, and pAMPK protein expression between Acsl1M-/-and control mice 
(Fig. 3D).  
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 Figure 3. Glycogen content, creatine kinase activity, SIRT1 and AMPK protein expressions. Acsl1 
deletion increased creatine kinase activity but did not affect protein expression of SIRT1 and AMPK. A: Glycogen 
content of fed and 17hr-fasted mice (nfed = 8-9/GT, nfast = 4/GT). B: Mitochondrial DNA content in white fibers of 
gastrocnemius (n = 5). C: Creatine kinase activity measured from blood serum (nKO = 12, nWT = 14). D: A western 
immunoblot using pAMPK, AMPK, SIRT1, and GAPDH antibody (n = 4). *P < 0.05 and ***P<0.0005, compared to 
control mice. 
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4.3 Muscle fiber typing via immunofluorescence and subcellular localization of nuclei. 
  We conducted immunofluorescence to analyze muscle fiber types. In Acsl1M-/-and control 
gastrocnemius, anti-MHC I and anti-MHC IIb antibodies were conjugated to a red-emitting 
fluorophore and a green-emitting fluorophore, respectively (Fig. 4A). We also further 
investigated muscle fiber damage by detecting central nuclei, a marker of myopathy24. Acsl1M-/- 
gastrocnemius has more central nuclei compared to that of control mice (Fig. 4B). However, 
central nuclei were absent in both Acsl1M-/- and control soleus (Fig. 4B).  
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Figure 4. Muscle fiber typing via immunofluorescence and subcellular localization of nuclei. Acsl1 plays a role 
in subcellular localization of nuclei in gastrocnemius tissue. A: Cross-sections of gastrocnemius were immunostained 
for MHC I (red), and MHC IIb (green). B: Cross-sections of gastrocnemius and soleus were immunostained for nuclei 
(blue) sialic acid and N-acetylglucosaminyl residues on outer cell surfaces (green). Arrows indicate central nuclei. 
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CHAPTER 5: DISCUSSION 
 
5.1 Muscle fiber type switch 
  Type I muscle fibers have more oxidative enzymes and mitochondria than type II muscle 
fibers, which have more glycolytic enzymes. As such, the preferred substrate for type I fibers is 
FA whereas for type II fibers is glucose. ACSL1 is specifically required in skeletal muscle 
tissues for fatty acid oxidation therefore Acsl1 deletion should result in a more glycolytic 
phenotype when FA use becomes limited. Thus, we expected that a switch from type I to type II 
muscle fibers would occur in Acsl1M-/-. 
Our data suggest that the deletion of Acsl1 in mice results in the increase of type I fibers 
and decrease of type IIa fibers. This is a surprising result because deletion of Acsl1, which is 
required in skeletal muscle fatty acid oxidation, should have decreased the need for 
mitochondria since FAs cannot enter the mitochondria for oxidative phosphorylation. An 
increase in the number of type I fibers would increase the number of mitochondria, thus 
maximizing oxidative phosphorylation. However, β-oxidation reduction from Acsl1 deletion 
should decrease the acyl-CoA concentration that would otherwise participate in oxidative 
phosphorylation. As such, we did not expect type I fibers to increase because they rely primarily 
on aerobic respiration. 
Cellular ATP production must still be maximized even though oxidative phosphorylation is 
limited. Because FA use is limited within the muscle, the major fuel substrate becomes glucose 
and amino acids. However, glycolysis may not be the major pathway for energy production 
since this would only provide 2 net ATPs per glucose molecule. As such, most ATP would still 
be generated via oxidative phosphorylation in the through NADH produced from pyruvate 
decarboxylation and the TCA cycle. To maximize ATP production, oxidative phosphorylation 
must be amplified, which resulted in mitochondrial increase as expression of β-oxidation genes  
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decreased. 
 
5.2 Molecular mechanism of fiber type switch 
  Our data suggest that Acsl1 deletion results in increased mitochondrial biogenesis. 
PGC1α, which is activated by SIRT1 deacetylation and AMPK phosphorylation, increases 
mitochondrial biogenesis28 and MHC I expression13. SIRT1, AMPK and pAMPK expression was 
similar in Acsl1M-/- and control gastrocnemius muscles thus the PGC1α activation must also be 
similar.  
  Because AMPK and pAMPK expression were similar, having similar cellular AMP/ATP 
between Acsl1M-/- and control gastrocnemius could be a strong possibility. Since increased 
AMP/ATP triggers the activation of AMPK and Acsl1M-/- and control gastrocnemius have similar 
AMP/ATP, the expression of activated PGC1α should also be similar.  
  Interestingly, if PGC1α activation was similar in Acsl1M-/- and control gastrocnemius then 
mitochondrial biogenesis should also be similar. However, Acsl1M-/- gastrocnemius has more 
mitochondria than control and if PGC1α activation is similar, then it must mean that 
mitochondrial biogenesis is activated by another pathway. Because we only measured SIRT1, 
AMPK, and pAMPK, it may be possible that other proteins are upregulated to increase PGC1α. 
 
5.3 ACSL1 knockout and muscle fiber damage 
  The increase in creatine kinase activity and the greater number of central nuclei suggest 
that muscle fiber damage is greater in Acsl1M-/- than control mice. It is possible that Acsl1M-/- has 
more intramuscular FAs than control mice when reduced β-oxidation limits FA use. Thus, FA 
accumulation will lead to crowding along the mitochondrial membrane, which will facilitate the 
entry of neutral FAs into the mitochondrial matrix30. With increased FAs that are more likely to 
be peroxidized, the mitochondria become more prone to oxidative damage by lipid peroxides  
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that would permeate the mitochondrial membrane25. The mitochondria would then release  
oxidative-inducing enzymes, which would permeate the cellular membrane and lead to cell 
death. The dead muscle would release various cellular substrates including creatine kinase. 
With more impaired mitochondria, oxidative capacity is reduced and therefore may lead to 
increased mitochondrial biogenesis as seen in our Acsl1M-/-.  
  Myocellular damage is often accompanied by myocellular regeneration, which is evident 
by the presence of central nuclei26. In Acsl1M-/-, the presence of central nuclei is more apparent 
in gastrocnemius than soleus, which contains mostly type I fibers. It is possible that the muscle 
fiber type switch from type II to type I could trigger muscle damage. In the absence of miR-133a, 
a muscle-specific microRNA, centronuclear myopathy (CNM) phenotype was also evident in 
type II fibers but not type I24. Similarly, the knockout of Srpk3, a muscle-specific protein kinase, 
also resulted in a CNM phenotype, specifically for type II fibers27. Both miR-133a and SRPK3 
are muscle-specific proteins involved in normal myofiber growth and development2424,32 and 
deficiency in either protein resulted in skeletal myopathy similar to Acsl1M-/-. Thus SRPK3, miR-
133a, and ACSL1 might act together to regulate muscle structure and nuclear localization. 
However, the mechanism through which this occurs remains largely unknown.  
 
5.4 Limitations 
  A major limitation of this study is that only one isoform of Acsl is knocked out. Thus, 
other isoforms of Acsl could play a role in activating FAs for β-oxidation which could then result 
in more subdued muscle fiber type switching, myocellular damage, and mitochondrial 
biogenesis. Other ACSL isoforms (ACSL 3, ACSL 4, ACSL5, and ACSL 6) have tissue-specific 
expression and differ in activity. ACSL3 and ACSL6 are predominantly expressed in skeletal 
muscle however ACSL1 have a more predominant role in FA oxidation use, constituting 90% of 
total ACSL activity4.  
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  Another limitation of this study is the sole use of gastrocnemius in most of our 
experiments. Different muscles have different composition of fiber types so it may be possible 
that the effects of muscle-specific Acsl1 KO might vary. Acsl1M-/- soleus has increased TAG, 
muscle weight to body weight ratio. Acsl1 deletion resulted in increased central nuclei for 
soleus, but the percentage of central nuclei is lower than that of gastrocnemius. In soleus, fatty 
acid oxidation and ACSL activity are reduced, but they are not as pronounced as in 
gastrocnemius. 
  It might also be possible that Acsl1M-/- require greater PDH activity than control mice to 
reach similar energy levels when oxidative phosphorylation is limited due to lack of oxidized FA; 
thus, it would be informative to measure PDH activity. While we did measure the proteins 
involved in PGC1α activation, measuring PGC1α protein levels could offer a more direct relation 
for the increased mitochondrial biogenesis. Phenotypically Acsl1M-/- mice cannot run as far as 
control mice when oxidative capacity of FA is limited4. Thus, when glucose and amino acids are 
exhausted, SIRT1 and AMPK expression may also differ between Acsl1M-/- and control 
gastrocnemius to meet energy requirements by increasing mitochondrial biogenesis through 
activation of PGC1α, which is also activated by exercise29. Although SDH provides a rough 
estimate of oxidative fibers, it does not distinguish between type IIa and type I because it only 
detects Complex II in mitochondria. To more accurately perform fiber type analysis, different 
muscle fibers should be labeled with fluorophores of different emission wavelengths. 
 
5.5 Future directions 
  In this work, we have explored the effects of absent ACSL1 on muscle fiber type 
switching. By knocking out Acsl1 in mice gastrocnemius, more MHC I mRNA was present 
compared to control mice. This suggests that glycolytic myofibers switched towards a more  
 
 
21 
oxidative fiber phenotype. However, this switch in phenotype results in muscle fiber damage  
which was shown through the increased creatine kinase activity and presence of centronuclear 
myopathy. It would be expected that Acsl1M-/- has more FAs and other lipid metabolites in 
skeletal myocytes. Therefore, AKT signaling would be impaired4 which could result in decreased  
signal transduction that would otherwise result from insulin binding. As such, Acsl1 may  
enhance insulin resistance, which could reveal the important role of Acsl1 in diabetes.   
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